Search

everythinglearnresearchcommunity

for

Search:↓

Scalp biopsies from dermatomyositis patients show chronic hair loss without scarring, with mucin and blood vessel changes being very common.

Some hair loss drugs can cause a unique type of hair loss that resembles both psoriasis and alopecia.

An 8-year-old girl with vitiligo developed extra hair growth on her knee after using tacrolimus ointment.

Dexamethasone-primed stem cell media shows promise in treating lupus by reducing symptoms and inflammation.

Folliculotropic mycosis fungoides has unique molecular features and cell interactions that could guide targeted therapy.

Some IBD patients on anti-TNFs developed severe skin issues, but ustekinumab helped.

Hydroxychloroquine may help delay skin damage in lupus patients.

Anifrolumab effectively improved symptoms and reduced steroid use in Japanese patients with systemic lupus erythematosus.

Trichostasis spinulosa can be diagnosed with a simple skin biopsy and treated with specific gels, but lesions may return after stopping treatment.

Recognizing and treating skin symptoms in essential thrombocythemia is crucial for patient quality of life.

Follicular dystrophy in immunocompromised patients may be linked to medication or viral factors and can improve with treatment changes.

The document concludes that DAB389-IL2 is promising for treating refractory cutaneous T-cell lymphoma, but more research is needed on its effectiveness and side effect management.

Linear lichen planopilaris can affect the trunk, not just the face.

Most clinicians follow discharge guidelines, many lupus patients don't use sunscreen regularly, dithranol is effective for psoriasis, biopsy methods should be based on lesion type, voriconazole may raise skin cancer risk, a new scale can help diagnose female hair loss early, and most melanomas may develop from existing moles.

The traditional Chinese medicine treatment improved symptoms and was more effective for SLE patients.

Lichen planopilaris is a chronic, scarring hair loss condition with no definitive cure, requiring accurate diagnosis and treatment to manage symptoms.

Hair loss in autoimmune blistering skin diseases varies and may regrow with disease control.

Methotrexate caused a rare skin rash in a rheumatoid arthritis patient, which resolved after stopping the drug.

Jieduquyuziyin prescription helps treat SLE with atherosclerosis by improving cholesterol removal and reducing inflammation.

An automated system can predict death risk in thin melanoma by analyzing immune cells.

A 72-year-old man was diagnosed with a rare skin form of Rosai-Dorfman disease after years of misdiagnosis.

A 13-year-old boy had both lichen planus and vitiligo, suggesting a possible link between the two conditions.

S-1 treatment led to a complete response in pancreatic cancer with manageable side effects.

Scalp pemphigus vulgaris can be effectively treated with low-dose prednisone and triamcinolone.

Monitor for early signs of myelosuppression, like hair loss, in patients on azathioprine to manage side effects.

Mycophenolate mofetil effectively improved skin pigmentation and itching in a woman with lichen planus pigmentosus and frontal fibrosing alopecia.

Excluding alopecia and mucous membrane components from the CLASI-A score reduces its effectiveness in capturing important disease activity.

Etretinate has only moderate effects on localized scleroderma and lichen sclerosus.

The boy's symptoms suggest a possible new medical condition.